CELG
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F2622057&ei=oIaaUpjiMKTisQeQfQ&usg=AFQjCNFre_2xJs3Pz7dIu3VxRc4Y-hqtzA
Celgene Corp Announces USFDA Approval For ABRAXANE
Friday, 12 Oct 2012 09:25am EDT
Celgene Corp announced that U.S. Food and Drug Administration (FDA) has approved ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.Â 
